Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes
Sun Pharmaceutical Industries Ltd., in Mumbai, India | Photo Credit: Reuters Sun Pharmaceutical Industries will extend Most Favoured Nation (MFN) pricing to state medicaid programmes of the U.S. It has also committed to MFN pricing for future innovative medicine launches. The announcement followed a White House ceremony on August 31, in which the U.S. government…
Read More “Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes” »